IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ascendis Pharma A/S

Q3 2019 vs Q4 2019

Comparing institutional holders between quarters

Quarters

Q4 2019Q3 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Vivo Capital, LLC
UNCHANGED
Shares2,552,237 from 2,552,237
Change0 (0%)
Value$298.7K (+$90.8K)
Filed 2020-02-25
Status
Vivo Capital, LLC
UNCHANGED2,552,2372,552,23700%$207.9K$298.7K+$90.8K2020-02-25
Showing 1 of 1 institutions